A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis

Summary

The purpose of the study is to explore the efficacy and safety of SUN13834 vs placebo in adult participants with atopic dermatitis.

Timeline

Start

2008-07-16

Primary completion

2009-04-09

Completion

2009-04-09

Outcome

Mixed primary results

registry analysis (superiority test); Placebo vs SUN13834 50 mg Tid; p = 0.519; ANCOVA NCT00717769 ↗

registry analysis (superiority test); Placebo vs SUN13834 50 mg Tid; p = 0.032; ANCOVA NCT00717769 ↗

registry analysis (superiority test); Placebo vs SUN13834 50 mg Tid; p = 0.533; ANCOVA NCT00717769 ↗

registry analysis (superiority test); Placebo vs SUN13834 50 mg Tid; p = 0.009; ANCOVA NCT00717769 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SUN13834	Unknown	—	Oral

Indications